Literature DB >> 10604259

ABO-incompatible bone marrow transplantation: the transfusion of incompatible plasma may exacerbate regimen-related toxicity.

R J Benjamin, J H Antin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10604259     DOI： 10.1046/j.1537-2995.1999.39111273.x

Source DB:  PubMed          Journal:  Transfusion        ISSN： 0041-1132            Impact factor:   3.157


× No keyword cloud information.
  12 in total

1.  Efficacy and Adverse Events of Platelet Transfusion Product-Specific Differences.

Authors:  Peter Hellstern
Journal:  Transfus Med Hemother       Date:  2008-03-17       Impact factor: 3.747

2.  2 Platelet Concentrates.

Authors: 
Journal:  Transfus Med Hemother       Date:  2009       Impact factor: 3.747

3.  ABO matching of platelet transfusions - "Start Making Sense". "As we get older, and stop making sense…" - The Talking Heads (1984).

Authors:  Neil Blumberg; Majed Refaai; Joanna Heal
Journal:  Blood Transfus       Date:  2015-02-02       Impact factor: 3.443

4.  Evaluation of Magnetized-Erythrocyte Group Antigens to Detect ABO Antibodies.

Authors:  O Nathalang; K Intharanut; P Sriwanitchrak; M Setthakarn; S Duan; H Wang; S Ding; Y Li
Journal:  Indian J Hematol Blood Transfus       Date:  2015-10-29       Impact factor: 0.900

5.  The characteristics of ABO antibodies in group O Thai blood donors.

Authors:  Kamontip Khampanon; Thanaporn Chanprakop; Pramote Sriwanitchrak; Manida Setthakarn; Sineenart Oota; Oytip Nathalang
Journal:  J Clin Lab Anal       Date:  2012-07       Impact factor: 2.352

6.  Alterations of platelet function and clot formation kinetics after in vitro exposure to anti-A and -B.

Authors:  Majed A Refaai; Jessie Carter; Kelly F Henrichs; Donna C Davidson; Stephen J Pollock; Ann E Casey; Sherry L Spinelli; Richard P Phipps; Charles W Francis; Neil Blumberg
Journal:  Transfusion       Date:  2012-05-25       Impact factor: 3.157

7.  An association of ABO non-identical platelet and cryoprecipitate transfusions with altered red cell transfusion needs in surgical patients.

Authors:  Majed A Refaai; Lawrence B Fialkow; Joanna M Heal; Kelly F Henrichs; Sherry L Spinelli; Richard P Phipps; Edward Masel; Brian H Smith; James P Corsetti; Charles W Francis; Paul E Bankey; Neil Blumberg
Journal:  Vox Sang       Date:  2011-03-18       Impact factor: 2.144

8.  Impact of ABO blood group mismatch in alemtuzumab-based reduced-intensity conditioned haematopoietic SCT.

Authors:  C K Brierley; T J Littlewood; A J Peniket; R Gregg; J Ward; A Clark; A Parker; R Malladi; P Medd
Journal:  Bone Marrow Transplant       Date:  2015-04-13       Impact factor: 5.483

Review 9.  A review of transfusion practice before, during, and after hematopoietic progenitor cell transplantation.

Authors:  James L Gajewski; Viviana V Johnson; S Gerald Sandler; Antoine Sayegh; Thomas R Klumpp
Journal:  Blood       Date:  2008-06-26       Impact factor: 22.113

10.  IgM anti-recipient ABO antibodies predict acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.

Authors:  Yoshitaka Zaimoku; Akiyoshi Takami; Hidehiro Sato; Maki Utsumi; Shinji Nakao
Journal:  Int J Hematol       Date:  2013-05-10       Impact factor: 2.490
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.